-1.png)
Urologie pro praxi 1/2016
Testosteron replacement therapy and cardiovascular risk
During the last years increase number of hypogonadal men with testosteron replacement therapy (TRT). Continually is assesed benefit this therapy with possible risk including cardiovascular diseases (CVD). In conformity with actually findings is not increase CVD risk by TRT.
Keywords: hypogonadal men, testosteron replacement therapy, cardiovascular diseases.
